Sixteen patients (age between 7-16 years old) with disruptive behavior disorder were treated with risperidone. A 6 months follow up was performed. We analyzed the treatment efficacy and the incidence of the principal and most frequent side effects: the hyperprolactinemia (observed in 15 patients, all asymptomatic, with normaliza- tion of prolactin levels after 6 months in roughly half of the cases) and the body weight increase(observed in 10 cases, with a mean increment of 4.8 kg). The treatment was effective in 14 over the 16 cases enrolled.
Spada, S., Bomba, M., Donati, C., Buzi, F., Nacinovich, R. (2011). Risperidone in età pediatrica: tollerabilità ed efficacia nei soggetti con disturbo del comportamento dirompente. GIORNALE DI NEUROPSICHIATRIA DELL'ETÀ EVOLUTIVA, 31(2), 149-153.
Risperidone in età pediatrica: tollerabilità ed efficacia nei soggetti con disturbo del comportamento dirompente
BOMBA, MONICASecondo
;NACINOVICH, RENATAUltimo
2011
Abstract
Sixteen patients (age between 7-16 years old) with disruptive behavior disorder were treated with risperidone. A 6 months follow up was performed. We analyzed the treatment efficacy and the incidence of the principal and most frequent side effects: the hyperprolactinemia (observed in 15 patients, all asymptomatic, with normaliza- tion of prolactin levels after 6 months in roughly half of the cases) and the body weight increase(observed in 10 cases, with a mean increment of 4.8 kg). The treatment was effective in 14 over the 16 cases enrolled.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Risperidone art. Giornale SINPIA.pdf
Solo gestori archivio
Descrizione: articolo
Dimensione
158.99 kB
Formato
Adobe PDF
|
158.99 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
